44. Design Thinking in Biotech w/ Chris Garabedian - CEO @ Xontogeny / Former CEO @ Sarepta
BIOS
Predictions and Hopes for the Future of Precision Medicine in Biotech
Exploring the genetic basis of diseases and the prospects of personalized drugs, envisioning a shift towards precision medicine and combination therapies in the biotech sector by 2050. Emphasizing the importance of mentorship and guidance for aspiring entrepreneurs to achieve success in developing innovative drugs and leading as CEOs.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
